Key Takeaways:
- CME Group (CME, Financial) unveiled a 10% increase in Q1 revenue, reaching $1.6 billion, alongside a record average daily volume of 29.8 million contracts.
- Analysts provided a mixed price target with an average of $272.07, suggesting a modest upside potential from its recent price.
- GuruFocus' GF Value estimates a slight downside for CME, highlighting the stock's current trade above fair value.
Strong Q1 Earnings Performance
CME Group Inc. (CME) posted an impressive Q1 non-GAAP earnings per share of $2.80. This financial achievement was fueled by a commendable 10% year-over-year increase in revenue, totaling $1.6 billion. A significant driver of this growth was the company reaching a record average daily volume of 29.8 million contracts. The growth spanned across all asset classes, demonstrating CME Group's robust position in the market.
Wall Street Analysts' Price Predictions
Wall Street analysts have set a one-year price target range for CME Group Inc. (CME, Financial) between $219.00 and $301.00, with an average target price of $272.07. This average target suggests a potential upside of 2.45% from the current trading price of $265.56. Investors seeking more detailed forecast data can visit the CME Group Inc (CME) Forecast page.
Brokerage Recommendations and GF Value Insights
The consensus recommendation from 18 brokerage firms ranks CME Group Inc. (CME, Financial) at an average of 2.6, placing it in the "Hold" category. The brokerage recommendation scale ranges from 1 (Strong Buy) to 5 (Sell), highlighting a cautious stance from analysts.
According to GuruFocus estimates, the GF Value for CME Group Inc. (CME, Financial) is projected to be $252.58 in one year. This projection suggests a potential downside of 4.89% from the current price of $265.56. The GF Value represents GuruFocus' estimation of the stock's fair trading value, derived from historical trading multiples, past business growth, and future forecasts of the company's performance. To delve deeper into these metrics, visit the CME Group Inc (CME) Summary page.